Placebo for AMG 890 clinical trials

A Double-blind, Randomized,Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a)

This study is looking at a new medicine called Olpasiran. It aims to see if Olpasiran can help prevent serious heart problems like heart attacks in people who have high levels of a specific fat in their blood called lipoprotein(a).